Laboratory Corporation of America Holdings Financial Statements (LH)
|
|
|
|
Report date
|
|
|
28.02.2023 |
31.12.2023 |
26.02.2024 |
25.02.2025 |
24.02.2026 |
|
04.05.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
11 864 |
12 162 |
12 162 |
13 009 |
13 952 |
|
14 144 |
|
Operating Income, bln rub |
|
|
1 437 |
1 124 |
725.6 |
1 087 |
1 516 |
|
1 560 |
|
EBITDA, bln rub |
? |
|
1 954 |
1 701 |
1 349 |
1 811 |
2 013 |
|
2 075 |
|
Net profit, bln rub |
? |
|
1 279 |
418.0 |
418.0 |
746.0 |
876.5 |
|
941.5 |
|
|
OCF, bln rub |
? |
|
1 956 |
1 328 |
1 328 |
1 586 |
1 641 |
|
1 814 |
|
CAPEX, bln rub |
? |
|
481.9 |
453.6 |
453.6 |
489.9 |
434.5 |
|
429.5 |
|
FCF, bln rub |
? |
|
1 474 |
874.1 |
874.1 |
1 096 |
1 206 |
|
1 384 |
|
Dividend payout, bln rub
|
|
|
195.2 |
254.0 |
254.0 |
243.1 |
240.7 |
|
240.3 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
15.3% |
60.8% |
60.8% |
32.6% |
27.5% |
|
25.5% |
|
|
OPEX, bln rub |
|
|
2 272 |
2 021 |
2 639 |
2 538 |
2 216 |
|
2 370 |
|
Cost of production, bln rub |
|
|
8 155 |
9 017 |
8 797 |
9 385 |
10 219 |
|
10 214 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
2.00 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
179.8 |
199.6 |
199.6 |
208.3 |
224.1 |
|
223.2 |
|
|
Assets, bln rub |
|
|
20 155 |
16 725 |
16 725 |
18 379 |
18 393 |
|
19 087 |
|
Net Assets, bln rub |
? |
|
10 097 |
7 875 |
7 875 |
8 052 |
8 620 |
|
8 729 |
|
Debt, bln rub |
|
|
6 246 |
5 954 |
5 954 |
7 273 |
7 204 |
|
7 241 |
|
Cash, bln rub |
|
|
320.6 |
536.8 |
536.8 |
1 519 |
532.3 |
|
981.1 |
|
Net debt, bln rub |
|
|
5 926 |
5 417 |
5 417 |
5 754 |
6 672 |
|
6 260 |
|
|
Ordinary share price, rub |
|
|
202.3 |
227.3 |
227.3 |
229.3 |
250.9 |
|
256.9 |
|
Number of ordinary shares, mln |
|
|
91.1 |
87.6 |
87.1 |
83.9 |
83.2 |
|
82.3 |
|
|
Market cap, bln rub |
|
|
18 429 |
19 911 |
19 797 |
19 240 |
20 873 |
|
21 145 |
|
EV, bln rub |
? |
|
24 354 |
25 328 |
25 214 |
24 994 |
27 545 |
|
27 404 |
|
Book value, bln rub |
|
|
850 |
-1 610 |
-1 610 |
-1 806 |
-1 766 |
|
-1 863 |
|
|
EPS, rub |
? |
|
14.0 |
4.77 |
4.80 |
8.89 |
10.5 |
|
11.4 |
|
FCF/share, rub |
|
|
16.2 |
9.98 |
10.0 |
13.1 |
14.5 |
|
16.8 |
|
BV/share, rub |
|
|
9.33 |
-18.4 |
-18.5 |
-21.5 |
-21.2 |
|
-22.6 |
|
|
EBITDA margin, % |
? |
|
16.5% |
14.0% |
11.1% |
13.9% |
14.4% |
|
14.7% |
|
Net margin, % |
? |
|
10.8% |
3.44% |
3.44% |
5.73% |
6.28% |
|
6.66% |
|
FCF yield, % |
? |
|
8.00% |
4.39% |
4.42% |
5.70% |
5.78% |
|
6.55% |
|
ROE, % |
? |
|
12.7% |
5.31% |
5.31% |
9.26% |
10.2% |
|
10.8% |
|
ROA, % |
? |
|
6.35% |
2.50% |
2.50% |
4.06% |
4.77% |
|
4.93% |
|
|
P/E |
? |
|
14.4 |
47.6 |
47.4 |
25.8 |
23.8 |
|
22.5 |
|
P/FCF |
|
|
12.5 |
22.8 |
22.6 |
17.6 |
17.3 |
|
15.3 |
|
P/S |
? |
|
1.55 |
1.64 |
1.63 |
1.48 |
1.50 |
|
1.49 |
|
P/BV |
? |
|
21.7 |
-12.4 |
-12.3 |
-10.7 |
-11.8 |
|
-11.4 |
|
EV/EBITDA |
? |
|
12.5 |
14.9 |
18.7 |
13.8 |
13.7 |
|
13.2 |
|
Debt/EBITDA |
|
|
3.03 |
3.18 |
4.01 |
3.18 |
3.31 |
|
3.02 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.44% |
0.00% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
4.06% |
3.73% |
3.73% |
3.77% |
3.11% |
|
3.04% |
|
| Laboratory Corporation of America Holdings shareholders |
